Ipsogen licensed worldwide rights from Stanford University to genomic mutations in the SH2B adaptor protein 3(SH2B3;LNK) gene to develop diagnostics

Stanford University

U.S. / Academic

Licensor

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

Ipsogen S.A.

France / Medical Devices and Diagnostics

$47.1m on 01/14/2011 [market cap]

Licensee

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

Active

Sample

01/01/2009

announced